John Leonard, CFA
Special situations, micro-cap, contrarian, CFA

PDI Is A Cash Rich Company With A Low Valuation And Multiple Growth Opportunities

Investment thesis

PDI (NASDAQ:PDII) is undervalued as higher investment spending results in temporary margin compression. However, a low EBITDA multiple and high net cash balance (69% of the market cap) provide downside protection while early evidence of a successful business transition should encourage investors that management is on the right track.

Company overview

PDII provides outsourced commercial services to pharmaceutical, biotech and healthcare companies in the U.S. The three operating segments include:

Sales services. This segment consists of the outsourced sales teams and EngageCE unit, which focuses on instilling best-practice treatment standards and procedures among healthcare practitioners.

Marketing services. This segment consists of the Group DCA and Voice units. Group DCA (acquired in November 2010) provides...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details